Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Gyre Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −11 vs. Q1 2023
- Shares held
- 2.27M
- −1.10M (−32.7%) vs. Q1 2023
- Total value
- $796.3K
- +$88.7K (+12.5%) vs. Q1 2023
- New holders
- 3
- 4 more added
- Sold out
- 14
- 9 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GWM Advisors LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 52 | $18 | 0.00% | +1+2.0% | Added |
| Wells Fargo & Company | 190 | $67 | 0.00% | +7+3.8% | Added |
| Advisor Group Holdings, Inc. | 215 | $76 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 277 | $97 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,285 | $452 | 0.00% | −92−6.7% | Reduced |
| Cutler Group LP | 5,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 12,900 | $4.54K | 0.00% | −50,000−79.5% | Reduced |
| Cubist Systematic Strategies, LLC | 14,683 | $5.16K | 0.00% | +14,683 | New |
| Keebeck Wealth Management, LLC | 20,000 | $7.03K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,983 | $9.15K | 0.00% | +25,983 | New |
| HSBC Holdings PLC | 32,528 | $11.5K | 0.00% | 00.0% | Unchanged |
| Colorado Capital Management, Inc. | 34,165 | $12.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 48,633 | $17.0K | 0.00% | +48,633 | New |
| Bank of America Corp | 48,468 | $17.0K | 0.00% | +16,355+50.9% | Added |
| Group One Trading, L.P. | 48,878 | $17.2K | 0.00% | −15,921−24.6% | Reduced |
| Susquehanna International Group, LLP | 55,043 | $19.4K | 0.00% | −3,204−5.5% | Reduced |
| Parallax Volatility Advisers, L.P. | 59,353 | $20.9K | 0.00% | −19,259−24.5% | Reduced |
| Barclays PLC | 60,204 | $21.2K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 66,951 | $23.5K | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 67,800 | $23.8K | 0.00% | −92,630−57.7% | Reduced |
| State Street Corp | 72,599 | $25.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 76,098 | $26.8K | 0.00% | +37,694+98.2% | Added |
| Northern Trust Corp | 86,412 | $30.4K | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 89,886 | $31.6K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 144,028 | $50.0K | 0.00% | −115,439−44.5% | Reduced |
| BlackRock Inc. | 153,657 | $54.0K | 0.00% | −16,247−9.6% | Reduced |
| Geode Capital Management, LLC | 270,033 | $94.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 774,386 | $272.0K | 0.00% | −101,500−11.6% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −272,313−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −200,638−100.0% | Sold out |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −43,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −81,851−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −50,750−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −50,314−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −44,435−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −21,423−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,855−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,345−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −10−100.0% | Sold out |